Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti-viral therapy in patients with chronic hepatitis B ALIMENTARY PHARMACOLOGY & THERAPEUTICS Hsu, Y., Jun, T., Huang, Y., Yeh, M., Lee, C., Ogawa, S., Cho, S., Lin, J., Yu, M., Nguyen, M. H., Tanaka, Y. 2018; 48 (10): 1128–37

View details for DOI 10.1111/apt.15006

View details for Web of Science ID 000449555100009